National Institute on Aging (NIA): Alzheimer Disease trials
The registry lists 38 Alzheimer Disease studies with National Institute on Aging (NIA) as lead sponsor. 2 are open to participants now and 3 have results posted.
Phase 1 3Phase 2 6Phase 3 9No phase 21(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Neuroplasticity Enhancement From Cognitive Training Reinforced by PsilocybinRecruitingNCT07721467Phase 2
- Amyloid PET Imaging in the Baltimore Longitudinal Study of AgingRecruitingNCT07099053
- Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults 55 Years Old or OlderCompletedNCT04421014Not applicableResults posted
- Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain FunctionCompletedNCT02460783Not applicableResults posted
- A Pilot Clinical Trial of Exendin-4 in Alzheimer's DiseaseTerminatedNCT01255163Phase 2Results posted
- On Site Sensors Monitoring Impacts of Cognitive Decline on ADLsStatus unknownNCT04871698
- Early Markers of Alzheimer's Disease: Structural and Functional Brain ChangesTerminatedNCT01867372
- Early Markers of Cognitive Change and Alzheimer s DiseaseCompletedNCT01867346
- Bisnorcymserine in Healthy Adult VolunteersCompletedNCT01747213Phase 1
- Research on Aging Project in Iceland: Second StageCompletedNCT01322568
- Pioglitazone in Alzheimer DiseaseCompletedNCT00982202Phase 2
- Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and DementiaStatus unknownNCT00966017
- Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down SyndromeStatus unknownNCT00965835
- Evolution of Memory Related ActivityStatus unknownNCT00902499
- Implications of Amyloid PathologyStatus unknownNCT00900770
- Memory Imaging of Normal AgingCompletedNCT00315575
- MIRAGE: Multi-Institutional Research in Alzheimer's Genetic EpidemiologyCompletedNCT00239759
- BONSAI: Biomarkers of Nonsteroidal Anti-InflammatoriesStatus unknownNCT00239746Phase 1
- Alzheimer's Caregiver Communication StudyCompletedNCT00182988
- PACT: Providers and Alzheimer's Caregivers TogetherCompletedNCT00182897Not applicable
- Anti-Oxidant Treatment of Alzheimer's DiseaseCompletedNCT00117403Phase 1
- Memory Aid for Informed Consent in Alzheimer's ResearchCompletedNCT00105612Not applicable
- Biomarkers and Early Alzheimer's DiseaseStatus unknownNCT00094952
- Predictors of Cognitive Decline in Normal AgingStatus unknownNCT00094939
- PET Changes in Alzheimer's Disease (AD)Status unknownNCT00094913
- Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IICompletedNCT00089882
- Huperzine A in Alzheimer's DiseaseCompletedNCT00083590Phase 2
- VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)CompletedNCT00056225Phase 3
- Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease StudyCompletedNCT00053599Phase 3
- Healthy Aging and Memory StudyCompletedNCT00034567
- Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer DiseaseCompletedNCT00013923Phase 2
- A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)CompletedNCT00004845Phase 2/3
- Agitation in Alzheimer's DiseaseCompletedNCT00000179Phase 3
- Multicenter Trial of Prednisone in Alzheimer's DiseaseCompletedNCT00000178Phase 3
- Estrogen Hormone ProtocolCompletedNCT00000177Phase 3
- Alzheimer's Disease Prevention TrialCompletedNCT00000176Phase 3
- Memory Impairment Study (Mild Cognitive Impairment Study)CompletedNCT00000173Phase 3
- Study of Melatonin: Sleep Problems in Alzheimer's DiseaseCompletedNCT00000171Phase 3